CHRS
Coherus Oncology, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$2.22
+$0.00
(+0.00%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $268.33M | EPS (ttm) | $0.55 | Current Price | $2.22 |
| Enterprise Value | $130.99M | Forward EPS | $-0.49 | Previous Close | $2.22 |
| P/E Ratio | 4.04 | ROA | -10.26% | 52W High | $2.62 |
| Forward P/E | -4.53 | ROE | - | 52W Low | $0.71 |
| PEG Ratio | - | Gross Margin | 56.31% | 50 Day Avg | $1.53 |
| P/S Ratio | 0.97 | Operating Margin | -364.99% | 200 Day Avg | $1.24 |
| P/B Ratio | 2.94 | Profit Margin | 55.80% | Volume | 2.06M |
| EV/EBITDA | -1.64 | Current Ratio | 1.24 | Avg Volume | 1.90M |
| EV/Sales | 0.47 | Quick Ratio | 1.19 | Beta | 1.02 |
| Employees | 158.00 | Debt/Equity | 61.89 | Shares Outstanding | 120.87M |
| Sector | Healthcare | Total Debt | $54.32M | Float Shares | 112.89M |
| Industry | Biotechnology | Total Cash | $191.66M | Short Float | 25.55% |
| Optionable | Yes | Cash/Share | $1.59 | Short Ratio | 25.37 |
| Dividend Yield | - | Book Value/Share | $0.76 | % Held by Insiders | 12.53% |
| Target Price | $6.75 | Revenue (TTM) | $277.73M | % Held by Institutions | 43.18% |